Medical Devices Industry | Healthcare Sector | Mr. David Hale CEO | LSE Exchange | FR0000032526 ISIN |
France Country | 2,920 Employees | 1 Jul 2024 Last Dividend | 23 Jan 2014 Last Split | - IPO Date |
Guerbet SA is a pioneering company dedicated to the development and marketing of diagnostic and interventional imaging solutions worldwide. Established in 1926, the company has consistently been at the forefront of the imaging field, offering a wide range of contrast media products, delivery systems, medical devices, and related solutions. Headquartered in Villepinte, France, Guerbet SA is committed to advancing medical imaging technology to improve patient diagnosis and treatment, with a strong emphasis on innovation, particularly in the realms of MRI, CT, and Cath Lab consumables and digital solutions.
Guerbet SA's product lineup is diverse, covering different aspects of medical imaging and treatment. Here are some of their key offerings: